home / Australia / CSL

CSL Market Cap

$77.44 B

+0.31 B

ASX:CSL.AX · June 02, 2025

Share price

$159.93

Enterprise Value

$132.02 B

Change (1-Year)

-11.4%

Global Rank

#257

Country Rank

Regions

Australia

Market cap

As of June 02, 2025, CSL (CSL.AX) has a market cap of $77.44 billion USD. According to our data, CSL is ranked No.257 in global market value.

Sector Rank:

Biotech #19 Pharmaceuticals #19

CSL.AX Market Capitalization Growth

30D Growth:

-3.5%

1 Years Growth:

-11.4%

3 Years Growth:

-5.4%

5 Years Growth:

-11.1%

10 Years Growth:

211.5%

15 Years Growth:

848.7%

20 Years Growth:

3383.7%

Total Growth:

49642%

CSL Market Cap Chart

YTD

10Y

15Y

20Y

MAX

CSL Market Cap CAGR Chart

CSL Market Cap History 1994 - 2025

Year	Market Cap	%Change
Jun 02, 2025	$77.44 B	-11.29%
Dec 31, 2024	$87.30 B	-1.15%
Dec 29, 2023	$88.31 B	0.91%
Dec 30, 2022	$87.51 B	0.13%
Dec 31, 2021	$87.40 B	3.72%
Dec 31, 2020	$84.27 B	3.72%
Dec 31, 2019	$81.24 B	50.75%
Dec 31, 2018	$53.89 B	32.64%
Dec 29, 2017	$40.63 B	42.66%
Dec 30, 2016	$28.48 B	-3.02%
Dec 31, 2015	$29.37 B	23.71%
Dec 31, 2014	$23.74 B	27.86%
Dec 31, 2013	$18.57 B	30.10%
Dec 31, 2012	$14.27 B	72.12%
Dec 30, 2011	$8.29 B	-9.44%
Dec 31, 2010	$9.16 B	14.38%
Dec 31, 2009	$8.00 B	-1.61%
Dec 31, 2008	$8.14 B	-6.14%
Dec 31, 2007	$8.67 B	68.81%
Dec 29, 2006	$5.13 B	55.88%
Dec 30, 2005	$3.29 B	47.30%
Dec 31, 2004	$2.24 B	66.28%
Dec 31, 2003	$1.34 B	-15.65%
Dec 31, 2002	$1.59 B	-57.52%
Dec 31, 2001	$3.75 B	32.65%
Dec 29, 2000	$2.83 B	79.86%
Dec 31, 1999	$1.57 B	58.62%
Dec 31, 1998	$0.99 B	48.33%
Dec 31, 1997	$0.67 B	64.57%
Dec 31, 1996	$0.41 B	52.32%
Dec 29, 1995	$0.27 B	71.40%
Dec 30, 1994	$0.16 B	100%

Similar Companies to CSL

Name	Market Cap	Market cap difference	Regions
Sanofi SNY	$125.43 B	5.543 B	France
Pfizer PFE	$133.09 B	-0.057 B	USA
Novartis NVS	$230.14 B	-0.007 M	Switzerland
AstraZeneca AZN	$222.70 B	-0.000 M	UK
GlaxoSmithKline GSK	$84.14 B	0.003 M	UK
Johnson & Johnson JNJ	$373.40 B	-0.005 M	USA
Merck MRK	$190.56 B	-0.025 B	USA
Bristol-Myers Squibb BMY	$99.18 B	-0.004 M	USA
Amgen AMGN	$154.43 B	0.000 M	USA
Eli Lilly LLY	$664.56 B	-0.020 M	USA
AbbVie ABBV	$329.43 B	0.012 M	USA
Biogen BIIB	$19.31 B	-0.000 M	USA
Regeneron Pharmaceuticals REGN	$53.32 B	0.897 B	USA

About CSL Inc.

Name

CSL FPO [CSL]

Website

https://www.csl.com.au

Headquarters

Melbourne,VIC

symbol

CSL.AX

CURRENCY

AUD

country

Australia

fullTimeEmployees

32698

exchange

ASX

firstTradeDateEpochUtc

1970/01/01

CSL.AX Market Cap Formula

Market Cap	=	CSL.AX Stock Price	*	CSL.AX Shares Outstanding
	=	$159.93	*	0.48 B
	=	$77.44 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe